Search

Your search keyword '"Kesaniemi, YA"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Kesaniemi, YA" Remove constraint Author: "Kesaniemi, YA"
37 results on '"Kesaniemi, YA"'

Search Results

1. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

2. The Lin28/let-7 axis regulates glucose metabolism

3. Erratum: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk (Nature Genetics (2010) 42 (105-116))

4. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk (vol 42, pg 105, 2010)

5. Fenofibrate intervention and event lowering in diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

6. Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.

7. Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes Real-world diabetes therapy in a clinical trial cohort

8. Identification of a Sudden Cardiac Death Susceptibility Locus at 2q24.2 through Genome-Wide Association in European Ancestry Individuals

9. A Genome-Wide Association Study Reveals Variants in ARL15 that Influence Adiponectin Levels

10. Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: Baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

13. Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women.

19. A Genome-Wide Association Search for Type 2 Diabetes Genes in African Americans

20. Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women

21. Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals

22. Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study.

23. A Low-Frequency Inactivating AKT2 Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk.

24. Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention.

25. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels.

26. Association analysis of peroxisome proliferator-activated receptor gamma polymorphisms and late onset Alzheimer's disease in the Finnish population.

27. Apolipoprotein E and colon cancer. Expression in normal and malignant human intestine and effect on cultured human colonic adenocarcinoma cells.

28. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

29. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study.

30. Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus.

31. Increased low density lipoprotein production associated with obesity.

32. Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man.

33. Dual defect in metabolism of very-low-density lipoprotein triglycerides. Patients with type 5 hyperlipoproteinemia.

34. Comparison of glucosylated low density lipoprotein with methylated or cyclohexanedione-treated low density lipoprotein in the measurement of receptor-independent low density lipoprotein catabolism.

35. Comparison of clofibrate and caloric restriction on kinetics of very low density lipoprotein triglycerides.

36. Overproduction of low density lipoproteins associated with coronary heart disease.

37. Receptor-mediated catabolism of low density lipoprotein in man. Quantitation using glucosylated low density lipoprotein.

Catalog

Books, media, physical & digital resources